Literature DB >> 6546847

Calcium and vitamin D metabolism in Guamanian Chamorros with amyotrophic lateral sclerosis and parkinsonism-dementia.

R Yanagihara, R M Garruto, D C Gajdusek, A Tomita, T Uchikawa, Y Konagaya, K M Chen, I Sobue, C C Plato, C J Gibbs.   

Abstract

We evaluated 16 Guamanian Chamorros with amyotrophic lateral sclerosis and 33 patients with parkinsonism-dementia for disturbances of calcium and vitamin D metabolism. The serum immunoreactive parathyroid hormone level was mildly elevated in 6 patients with amyotrophic lateral sclerosis and in 5 patients with parkinsonism-dementia. There were significant positive correlations between serum immunoreactive parathyroid levels and duration of illness in male patients with motor neuron disease, but not in female patients or in patients with parkinsonism-dementia. Intestinal absorption of calcium, as assessed by serum and urinary activity of calcium 47 following oral administration, was decreased in 2 patients with amyotrophic lateral sclerosis and in 4 patients with parkinsonism-dementia, all of whom had low levels of serum 1,25-dihydroxyvitamin D. Reductions in cortical bone mass were striking in patients with motor neuron disease. A significant negative correlation was found between the percentage of cortical area of the second metacarpal bone and muscle atrophy and weakness, and significant positive correlations were found between degree of immobility and ratio of urinary hydroxyproline to creatinine in patients with amyotrophic lateral sclerosis and parkinsonism-dementia. In general, abnormalities in calcium metabolism were subtle. Thus, if the demonstrated deposition of metals, particularly calcium and aluminum, in central nervous system tissues of Guamanians with these two conditions is a cause of the diseases and of the early appearance of neurofibrillary tangles in neurons, the accumulation has apparently occurred long before onset of symptoms, and detectable abnormalities of calcium and vitamin D metabolism may already have been corrected.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6546847     DOI: 10.1002/ana.410150108

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

Review 1.  Clinical pharmacology of old age syndromes.

Authors:  C Broadhurst; K C M Wilson; M T Kinirons; A Wagg; J K Dhesi
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

2.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

4.  Relationship among aluminum, osteoporosis, and Alzheimer's disease.

Authors:  C Cooper; C N Martyn
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

5.  Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Authors:  R M Garruto; R Yanagihara; D C Gajdusek
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

6.  Aluminium and calcium in soil and food from Guam, Palau and Jamaica: Implications for amyotrophic lateral sclerosis and parkinsonism-dementia syndromes of Guam.

Authors:  D R Crapper McLachlarf; C D McLachlan; B Krishnan; S S Krishnan; A J Dalton; J C Steele
Journal:  Environ Geochem Health       Date:  1989-06       Impact factor: 4.609

7.  Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue.

Authors:  Laura R Snyder; Reyniel Cruz-Aguado; Martin Sadilek; Douglas Galasko; Christopher A Shaw; Thomas J Montine
Journal:  Toxicol Appl Pharmacol       Date:  2009-08-28       Impact factor: 4.219

8.  One hundred pancreas transplants at a single institution.

Authors:  D E Sutherland; F C Goetz; J S Najarian
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

9.  Basal ganglia calcifications and ALS syndrome.

Authors:  A Scarpitta; G Pisciotta; B Fierro
Journal:  Ital J Neurol Sci       Date:  1994-06

Review 10.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.